Electronic Signatures provider, ARX, Joins SAFE-BioPharma Association as Vendor Partner

Algorithmic Research (ARX), a leading worldwide provider of digital signatures and data security solutions, has joined the SAFE-BioPharma Association’s Vendor Partner Program, the company announced today.

ARX’s CoSign® enables users to electronically sign documents using standard electronic signatures within applications such as Microsoft Word, Excel, Adobe Acrobat and AutoCAD. Using electronic signatures, life sciences organizations may replace handwritten signatures, sealing documents with legally-binding signatures as well as saving the costs and time associated with paper-based processes.

"We are pleased that ARX has joined the SAFE Vendor Partner Program, says Mollie Shields-Uehling, president and CEO of SAFE-BioPharma Association

"ARX’s membership to the SAFE-BioPharma Vendor Partner Program is an important step toward meeting a growing industry need for secure digital signature solutions that are compliant with regulations such as 21 CFR Part 11 and GxP," says Dr. Gadi Aharoni, CEO of ARX.

"In time, we expect to be able to offer SAFE members a turnkey electronic signature solution that, for the first time, will enable them to guarantee the data integrity and signer authenticity of all the documents they handle," says Aharoni.

CoSign's electronic signatures are based on PKI (Public Key Infrastructure), a mature and proven technology which ensures signer authenticity, data integrity and non-repudiation of documents.

SAFE-BioPharma Association is the non-profit association that created and manages the SAFE™ digital identity and signature standard for the pharmaceutical and healthcare industries. Through the SAFE standard, the association promotes interoperability and integration among researchers, vendors, regulators, clinicians and other pharmaceutical and healthcare stakeholders. The SAFE standard provides a secure, enforceable, and regulatory compliant way to verify the identities of parties involved in business-to-business and business-to-regulator electronic transactions. SAFE stands for "Signatures and Authentication For Everyone." The Association's founder-members include AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Procter & Gamble, and Sanofi-Aventis. For more information, visit www.safe-biopharma.org

About CoSign®

CoSign® is an electronic signature solution. Based on standard PKI technology, CoSign guarantees signer authenticity, data integrity, and non-repudiation of electronic documents.
With CoSign’s standard electronic signatures you can sign & seal electronic documents; expedite business processes; reduce costs; Increase security and Comply with regulations.
CoSign electronic signature solution supports all major applications and file formats (Word, Excel, Outlook, PDF, TIFF, AutoCAD, InfoPath and many more).
With a rapid deployment; unique centralized approach; built-in integration with an organization's existing user-management directory systems; and extensive 3rd party application support, CoSign guarantees a quick ROI
Additional information about CoSign is available at www.arx.com/products/cosign-digital-signatures.php

About Algorithmic Research (ARX)

Algorithmic Research (ARX) is a leading global provider of electronic-signature and data-security solutions. The company offers a wide range of high-end and state-of-the-art products and services designed to simplify, secure, and accelerate electronic transactions. ARX specializes in designing and implementing easy to use, simple to deploy, electronic signature and security solutions, combining software and hardware products, for small, medium and large computing environments.

ARX has more than 18 years of experience in assisting financial institutions, governmental organizations and commercial sectors to secure and streamline their processes and transactions.

Additional information about ARX Life Science practice is available at www.arx.com/industries/lifesciences.php.